arrow
E

Elżbieta Senkus

Medical University of Gdańsk
H指数:60
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: insights from the EUSOMA database
2026-01-300
PRE
Interplay between red blood cells and circulating tumor cells: clinical and molecular evidence of a putative pro-metastatic axis

红细胞与循环肿瘤细胞之间的相互作用:一个潜在促转移轴的临床与分子证据

2025-11-060
OAAI
Overall Survival with Abemaciclib in Early Breast Cancer

早期乳腺癌中使用Abemaciclib的总体生存率

2025-10-170
OAAI
Characterizing epithelial-mesenchymal transition-linked heterogeneity in breast cancer circulating tumor cells at a single-cell level

在单细胞水平上表征乳腺癌循环肿瘤细胞中与上皮-间质转化相关的异质性

2025-10-010
OAAI
Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial
2025-04-010
OAAI
Multiple breast cancer: EUSOMA real world data

多发性乳腺癌:EUSOMA真实世界数据

BREAST
IF7.9
2025-02-010
OAAI
Post-operative whole breast irradiation lowers mortality in early- stage, luminal A-like, low-risk, older breast cancer patients: an analysis from the EUSOMA database

术后全乳腺照射可降低早期、腔A型、低风险、老年乳腺癌患者的死亡率:一项来自EUSOMA数据库的分析

BREAST
IF7.9
2025-02-010
OAAI
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial

进展性前列腺癌患者开始使用多西他赛联合或不联合恩扎卢替尼时的液体活检:PRESIDE 3b期试验的生物标志物研究

2025-02-011
OAAI
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

6th和7th晚期乳腺癌管理国际共识指南 (ABC指南6和7)

BREAST
IF7.9
2024-08-0122
OAAI
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
2024-07-252
OAAI
Effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer: the multinational randomized controlled PREFERABLE-EFFECT study
2024-05-020
PRE
Reporting on invasive lobular breast cancer in clinical trials: a systematic review
2024-03-205
OA
Effects of exercise on fatigue and health-related quality of life (HRQoL) in patients with metastatic breast cancer (mBC) - do the positive effects apply to all? The multinational randomized controlled PREFERABLEEFFECT study
2024-03-010
PRE
Adjuvant abemaciclib plus endocrine therapy for HR+, HER2-, high-risk early breast cancer: Results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes
2023-10-0110
OA